Skip to content

Utilizing Technology to Promote Cancer Prevention

Utilizing Technology to Promote Cancer Prevention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03810053
Enrollment
290
Registered
2019-01-18
Start date
2019-03-01
Completion date
2021-07-14
Last updated
2021-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Knowledge, Attitudes, Practice

Brief summary

The goal of the program is to develop an online module/a health application for cell phones which will share didactic information regarding cancer prevention and early detection measures. These module/application will be developed, and be tested among volunteers for feedback. In the future, these module/application will be disseminated widely to address cancer health disparity particularly in Arkansas.

Detailed description

The application or the online module will play a short didactic explanation video that will provide information about cancers and benefits of uptake of cancer prevention and early detection measures. It is currently unknown which method will be used, the online module or the application for the purpose. The study participants will be subjected to only one method (once the method have been finalized and created). The video content will engulf information about cervical, breast, colorectal and lung cancer prevention and early detection. After the video, the application or the module will capture information on gender, age, smoking status, body mass index and positive cancer history in family. Watching the video and answering the questions will take approximately 5 minutes. The study participants will download the application on their personal cell phones and the data collected will be linked to identifying information in case they choose to receive the compensation and opt for the 6-month follow-up. Based on the responses provided, and the age and the gender, the participants will be provided with a list of cancer prevention and early detection measure(s). A subset of the study participants from ARResearch (only those who have agreed for the 6-month follow-up) will be asked if they are willing to be contacted by the study staff after 6 ±1 months (from the date of enrollment in the study) to enquire if they received/adopted the screening measures(s) that were suggested based on their age, gender and family history. They will be asked whether it is OK to call and/or e-mail them for more information to better describe barriers to obtaining cancer prevention and screening measures.

Interventions

BEHAVIORALMobile App/Online Module

Short didactic explainer video that will provide information about cancers and benefits of uptake of cancer prevention and early detection measures.

Sponsors

University of Arkansas
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Any ARResearch volunteer * 18 years or older in age * Have access to a personal cell phone and/or computer

Exclusion criteria

* Unable to give an informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants to Learn New Informationup to 6 MonthsPercentage of participants that indicated they learned something new about cancer prevention measures.
Percentage of Participants to Identify Needed Interventionsup to 6 monthsPercentage of participants that identified interventions that they have not yet adopted from the use of the health application.

Countries

United States

Participant flow

Participants by arm

ArmCount
Mobile App/Online Module
Subjects will watch a short video containing information about cancers and benefits of uptake cancer prevention and early detection measures. Information regarding gender, age, smoking status, BMI and positive cancer history in family will be captured. Subjects will be provided with a list of cancer prevention and early detection measures based on the responses provided. Mobile App/Online Module: Short didactic explainer video that will provide information about cancers and benefits of uptake of cancer prevention and early detection measures.
290
Total290

Baseline characteristics

CharacteristicMobile App/Online Module
Age, Customized
18-29
63 participants
Age, Customized
30-39
84 participants
Age, Customized
40-49
76 participants
Age, Customized
>/=50
67 participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
29 Participants
Race (NIH/OMB)
More than one race
12 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
239 Participants
Region of Enrollment
United States
290 participants
Sex/Gender, Customized
Female
200 Participants
Sex/Gender, Customized
Male
87 Participants
Sex/Gender, Customized
Neither
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Percentage of Participants to Identify Needed Interventions

Percentage of participants that identified interventions that they have not yet adopted from the use of the health application.

Time frame: up to 6 months

Population: 290 participants 18 and over.

ArmMeasureValue (NUMBER)
Mobile App/Online ModulePercentage of Participants to Identify Needed Interventions41.4 percentage of participants
Primary

Percentage of Participants to Learn New Information

Percentage of participants that indicated they learned something new about cancer prevention measures.

Time frame: up to 6 Months

Population: 290 participants ages 18 and over.

ArmMeasureValue (NUMBER)
Mobile App/Online ModulePercentage of Participants to Learn New Information38.6 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026